Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

David Douglass

Concepts (70)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Sarcoma
2
2025
70
1.030
Why?
Fibromatosis, Aggressive
1
2022
3
0.770
Why?
Adenomatous Polyposis Coli
1
2022
5
0.770
Why?
Rhabdomyosarcoma, Alveolar
1
2021
8
0.720
Why?
Li-Fraumeni Syndrome
1
2021
12
0.720
Why?
Receptors, Tumor Necrosis Factor, Member 14
1
2020
5
0.670
Why?
Proto-Oncogene Proteins c-ets
1
2020
8
0.670
Why?
Sarcoma, Ewing
1
2020
28
0.650
Why?
Tumor Suppressor Protein p53
1
2021
224
0.630
Why?
Mutation
2
2022
1318
0.610
Why?
Antineoplastic Agents
2
2025
1214
0.550
Why?
DNA-Binding Proteins
1
2020
424
0.540
Why?
Transcription Factors
1
2020
564
0.510
Why?
Soft Tissue Neoplasms
2
2025
55
0.430
Why?
Breast Neoplasms
1
2021
1199
0.390
Why?
Prognosis
3
2024
2093
0.310
Why?
Adolescent
3
2024
6681
0.260
Why?
Ifosfamide
1
2024
9
0.220
Why?
Child, Preschool
2
2024
4001
0.220
Why?
Neoplasm Grading
1
2024
125
0.210
Why?
Osteoblastoma
1
2023
2
0.200
Why?
Osteoma, Osteoid
1
2023
4
0.200
Why?
Neuroblastoma
1
2023
50
0.200
Why?
Protein Kinase Inhibitors
1
2025
225
0.200
Why?
Child
3
2025
7147
0.190
Why?
Genes, APC
1
2022
4
0.190
Why?
Doxorubicin
1
2024
242
0.190
Why?
Combined Modality Therapy
1
2024
634
0.190
Why?
Survival Rate
1
2024
945
0.180
Why?
Bone Neoplasms
1
2023
184
0.170
Why?
Proto-Oncogene Protein c-fli-1
1
2020
8
0.170
Why?
RNA-Binding Protein EWS
1
2020
13
0.170
Why?
Ultrasonography, Doppler, Color
1
2020
33
0.160
Why?
Cyclin D1
1
2020
57
0.160
Why?
Neoplasm Recurrence, Local
1
2024
630
0.160
Why?
Chemotherapy, Adjuvant
1
2020
121
0.160
Why?
Humans
8
2025
52114
0.160
Why?
DNA Copy Number Variations
1
2020
117
0.160
Why?
Incidence
1
2022
1070
0.150
Why?
Carboxymethylcellulose Sodium
1
2018
2
0.150
Why?
Glycerol
1
2018
19
0.150
Why?
Dry Eye Syndromes
1
2018
11
0.150
Why?
Follow-Up Studies
1
2024
2282
0.150
Why?
Gene Expression Profiling
1
2023
1101
0.140
Why?
Female
4
2024
28055
0.140
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2024
1020
0.140
Why?
Prospective Studies
1
2024
2424
0.140
Why?
Immunohistochemistry
1
2020
975
0.130
Why?
Infant
1
2024
3660
0.120
Why?
Skin Neoplasms
1
2020
499
0.110
Why?
Young Adult
1
2024
4307
0.110
Why?
Magnetic Resonance Imaging
1
2020
1518
0.100
Why?
Treatment Outcome
2
2020
5456
0.100
Why?
Retrospective Studies
1
2024
6610
0.090
Why?
Adult
2
2024
14095
0.080
Why?
Male
2
2024
26652
0.060
Why?
Heterogeneous-Nuclear Ribonucleoproteins
1
2023
2
0.050
Why?
Polypyrimidine Tract-Binding Protein
1
2023
11
0.050
Why?
Proto-Oncogene Proteins c-fos
1
2023
60
0.050
Why?
Transcriptome
1
2023
363
0.040
Why?
Diagnosis, Differential
1
2023
1031
0.040
Why?
Administration, Ophthalmic
1
2018
2
0.040
Why?
Viscosity
1
2018
8
0.040
Why?
Tears
1
2018
11
0.040
Why?
Ophthalmic Solutions
1
2018
20
0.040
Why?
Drug Combinations
1
2018
134
0.040
Why?
Double-Blind Method
1
2018
718
0.030
Why?
Infant, Newborn
1
2023
2859
0.030
Why?
Aged
1
2018
10142
0.010
Why?
Middle Aged
1
2018
13028
0.010
Why?
Douglass's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description